Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well tolerated. Rappersberger K, Komar M, Ebelin ME, Scott G, Burtin P, Greig G, Kehren J, Chibout SD, Cordier A, Holter W, Richter L, Oberbauer R, Stuetz A, Wolff K. J Invest Dermatol. 2002 Oct;119(4):876–87.

Infections with herpes simplex and varicella-zoster viruses during pregnancy. Marculescu R, Richter L, Rappersberger K. Hautarzt. 2006 Mar;57(3):207–12, 214–6.

A long-term study of a patient with anti-p200 pemphigoid: correlation of autoantibody levels with disease activity and an example of epitope spreading. Monshi B, Groth S, Richter L, Schmidt E, Zillikens D, Rappersberger K. Br J Dermatol. 2012 Nov;167(5):1179–83.

Pityriasis rubra pilaris types 1 and 2: different responses to treatment with TNF-alpha antagonists. Vujic I, Richter L, Bartsch K, Monshi B, Rappersberger K. Eur J Dermatol. 2013 Nov-Dec;23(6):895–6.
Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics. Sator P, Richter L, Saxinger W, Vasiljevic M, Stingl G. J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1742–9.

Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria. Inzinger M, Wippel-Slupetzky K, Weger W, Richter L, Mlynek A, Fleischander B, Scheurecker C, Sandor N, Mairhofer D, Sator PG, Moser-Oberthaler S, Häring N, Viznerova P, Painsi C, Tanew A, Ponholzer P, Tatarski R, Brenner W, Stingl G, Salmhofer W, Rappersberger K, Klein G, Saxinger W, Auböck J, Kölli C, Trautinger F, Steiner A, Ratzinger G, Strohal R, Riedl E, Lange-Asschenfeldt B, Pehamberger H, Volc-Platzer B, Selhofer S, Legat FJ, Müllegger R, Reider N, Schmuth M, Hintner H, Hofer A, Gruber-Wackernagel A, Aberer W, Quehenberger F, Wolf P. Acta Derm Venereol. 2015 Aug 13.
Phrynoderma and acquired acrodermatitis enteropathica in breastfeeding women after bariatric surgery. Monshi B, Stockinger T, Vigl K, Richter L, Weihsengruber F, Rappersberger K. J Dtsch Dermatol Ges. 2015 Nov;13(11):1147–54.

Pyoderma gangrenosum during pregnancy – treatment options revisited. Vigl K, Posch C, Richter L, Monshi B, Rappersberger K. J Eur Acad Dermatol Venereol. 2016 Nov;30(11):1981–1984
Systemic lupus erythematosus : Unusual cutaneous manifestations. Stockinger T, Richter L, Kanzler M, Melichart-Kotik M, Pas H, Derfler K, Schmidt E, Rappersberger K. Hautarzt. 2016 Dec;67(12):970–981.

Cutaneous involvement in chronic inflammatory bowel disease : Crohn’s disease and ulcerative colitis. Richter L, Rappersberger K. Hautarzt. 2016 Dec;67(12):940–947.

Etanercept, adalimumab, and ustekinumab in psoriasis: analysis of 209 treatment series in Austria. Richter L, Vujic I, Sesti A, Monshi B, Sanlorenzo M, Posch C, Rappersberger K. J Dtsch Dermatol Ges. 2017 Mar;15(3):309–317.

2.Fortbildungsveranstaltung der AG Biologika der ÖGDV, 25. März 2017, Wien.
Richter L, Müllegger R. J Dtsch Dermatol Ges. 2017 Jun;15(6):683–684

Apremilast in psoriasis – a prospective real-world study. Vujic I, Herman R,
Sanlorenzo M, Posch C, Monshi B, Rappersberger K, Richter L. J Eur Acad
Dermatol Venereol. 2018 Feb;32(2):254–259.

Quality of life and treatment goals in psoriasis from the patient perspective: results of an Austrian cross-sectional survey. Wolf P, Weger W, Legat F, Painsi C, Saxinger W, Müllegger R, Sator P, Ratzinger G, Selhofer S, Richter L, Salmhofer W, Lange-
Asschenfeldt B, Trautinger F, Mlynek A, Strohal R, Augustin M, Quehenberger F. J
Dtsch Dermatol Ges. 2018 Aug;16(8):981–990.

Clinical characteristics and treatment outcomes of 36 pyoderma gangrenosum
patients – a retrospective, single institution observation. Platzer KD, Kostner L, Vujic I, Monshi B, Richter L, Rappersberger K, Posch C. J Eur Acad Dermatol Venereol. 2019 Jul 16 Clinical melanoma characteristics and survival‑a single-center retrospective study between 2000 and 2010. Feichtenschlager V, Weihsengruber F, Richter L, Vujic I, Rappersberger K, Posch C. Wien Med Wochenschr. 2019 Oct;169(13–14):323–330

Österreichischen Gesellschaft für Dermatologie und Venerologie (ÖGDV)
European Academy of Dermatology and Venerology (EADV)
Arbeitsgemeinschaft (AG) für Biologika und Immuntherapie bei chronisch entzündlichen Hautkrankheiten der ÖGDV
AG für Dermatohistopathologie der ÖGDV

Medikamentöse Tumortherapie in der Dermato-Onkologie“, Diplom der ADO (Arbeitsgruppe Dermato-Onkologie der Deutschen Krebsgesellschaft)
„Klinischer Prüfarzt“, Diplom der Österreichischen Ärztekammer
„Fortbildungs Diplom“ der Österreichischen Ärztekammer